Shionogi & Co. Overview

  • Founded
  • 1878

Founded
  • Status
  • Public

  • Employees
  • 6,441

Employees
  • Stock Symbol
  • 4507

Stock Symbol
  • Investments
  • 16

  • Share Price
  • $50.19

  • (As of Thursday Closing)

Shionogi & Co. General Information

Description

Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Other Devices and Supplies
Stock Exchange
TKS
Primary Office
  • 1-8, Doshomachi 3-chome
  • Chuo-ku
  • Osaka, 541-0045
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shionogi & Co. Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$50.19 $50.27 $44.88 - $73.31 $15.1B 301M 1.83M $3.37

Shionogi & Co. Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 14,972,802 14,972,802 12,711,382 11,851,666
Revenue 2,983,161 2,983,161 2,802,512 3,065,974
EBITDA 1,127,464 1,127,464 1,246,856 1,331,184
Net Income 1,016,394 1,016,394 1,054,871 1,123,795
Total Assets 9,427,449 9,427,449 9,055,763 8,084,300
Total Debt 54,683 54,683 72,401 75,430
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shionogi & Co. Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shionogi & Co.‘s full profile, request access.

Request a free trial

Shionogi & Co. Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and di
Pharmaceuticals
Osaka, Japan
6,441 As of 2022
00000
000000000 00000

00000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
000000000000000
Basel, Switzerland
000000 As of 0000
00.000
00.00 0000-00-00
00000000000 00.000

000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000000000000
Yilan City, Taiwan
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shionogi & Co. Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roche Holding Corporation Basel, Switzerland 000000 00.000 00000000000 00.000
0000000 0000000000 Corporation Yilan City, Taiwan 00
000 000000 Corporate Backed or Acquired Monheim, Germany 0000 000000&0
You’re viewing 3 of 3 competitors. Get the full list »

Shionogi & Co. Patents

Shionogi & Co. Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210069204-A1 Dosage of baloxavir marboxil for pediatric patients Pending 13-Aug-2019 00000000000
EP-3714889-A1 Baloxavir for the prevention of transmission of influenza virus Pending 29-Mar-2019 00000000000 0
AU-2020254906-A1 Compound and method for the prevention of transmission of influenza virus Pending 29-Mar-2019 00000000000
CA-3129668-A1 Compound and method for the prevention of transmission of influenza virus Pending 29-Mar-2019 00000000000
US-20200330473-A1 Compound and method for the prevention of transmission of influenza virus Pending 29-Mar-2019 A61K31/5383
To view Shionogi & Co.’s complete patent history, request access »

Shionogi & Co. Executive Team (6)

Name Title Board Seat Contact Info
Isao Teshirogi Ph.D Chief Executive Officer & Board Member
Nathan Mccutcheon Chief Operating Officer
Takeshi Shiota Corporate Officer, Senior Vice President of DX Promotion Division
Toshiro Koike Executive
Takuko Sawada Board Member & Executive Vice President
You’re viewing 5 of 6 executive team members. Get the full list »

Shionogi & Co. Board Members (7)

Name Representing Role Since
0000 000000000 00.0 Shionogi & Co. Chief Executive Officer & Board Member 000 0000
0000000 0000 Shionogi & Co. Outside Director 000 0000
000000 000000 Shionogi & Co. Board Member & Executive Vice President 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Shionogi & Co. Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shionogi & Co. Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shionogi & Co.‘s full profile, request access.

Request a free trial

Shionogi & Co. Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 27-Dec-2021 00000 0000 00.000 Diagnostic Equipment
00000 0000000 05-Mar-2020 0000000000 00000 Drug Discovery 0000 0000
000000 08-May-2019 00000 0000 0000 Diagnostic Equipment
00000 0000000 03-Jan-2019 00000 0000 000.00 Drug Discovery 0000 0000
KNOW Bio 07-Dec-2018 Early Stage VC 0000 Drug Discovery 0000000 0
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

Shionogi & Co. Subsidiaries (1)

Company Name Industry Location Founded
00000 000000000000 Drug Discovery Grand Rapids, MI 0000
To view Shionogi & Co.’s complete subsidiaries history, request access »

Shionogi & Co. Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 15-Dec-2014 00000 00000 00 00.000 Completed
  • 00000000 & 00.
To view Shionogi & Co.’s complete exits history, request access »